BioNano Genomics News and Activities

BioNano Genomics is a company listed under the stock ticker BNGO (US).

View the org chart displaying its 21 main executives

Most searched biographies at BioNano Genomics

• Albert Luderer, Interim Chief Executive Officer and Chairman of th...
• David Barker, Director
• Kristiina Vuori, Director

Popular executive movements at BioNano Genomics

• Christopher Twomey who was Director, becomes Lead Independent Director  (posted on May 8 2026).
• Albert Luderer, who was Chairman of the Board, is promoted to Interim President and Chief Executive Officer  (posted on May 8 2026).

Create your alert
to follow the executive moves at BioNano Genomics.

BioNano Genomics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by BioNano Genomics

• Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting | Bionano Genomics, Inc.
• Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress | Bionano Genomics, Inc.
• Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting | Bionano Genomics, Inc.
• Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 | Bionano Genomics, Inc.
• Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow’s Performance and Ability to Detect More SVs than LRS at Lower Cost | Bionano Genomics, Inc.
• Bionano to Present at the 2023 Stifel Healthcare Conference | Bionano Genomics, Inc.
• Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease | Bionano Genomics, Inc.
• Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia | Bionano Genomics, Inc.
• Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development | Bionano Genomics, Inc.
• Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health | Bionano Genomics, Inc.
• View more press releases Close

Social media about BioNano Genomics

• BioNano Genomics on Wikipedia, Google News & Yahoo Finance
• BioNano Genomics on LinkedIn, X (Twitter) & YouTube